Other Insights from FSI

This report covers key events and emerging trends in the Robotic Assisted Surgery (RAS) market through Q1 2026. It includes a key events snapshot across leading platforms, a strategic deep dive into J&J's multi-platform RAS portfolio, and an overview of endoluminal robotics. Additionally, it covers the accelerating shift to ASCs, AI as a competitive differentiator, and shifting international dynamics across Asia-Pacific and Europe.

The report analyzes revenue growth and investment trends across key Digital Health segments and stakeholders (including Payers, Big Four Tech and Diversified Medtech Companies). The Spotlight explores how LLMs are reshaping care delivery.

Bioprocessing Innovation Roadmap and Opportunity Prioritization
Urology Device Asia Market Landscape and Positioning Strategy
AI-Enabled Clinical Workflow Tool Fundraising Support
AI-Enabled Cardiac Device Market Entry Strategy
Academic Health System Innovation Fund Portfolio Review
Novel Prostate Cancer Screening Test Go-to-Market Strategy
Endocrine Therapy Adverse Event Market Impact Study
Medical Supplies Due Diligence